Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free GMVDF Stock Alerts

G Medical Innovations (GMVDF) Competitors

Compare

GMVDF vs. SDCCQ, TTOO, VRAYQ, AFIB, and UTRS

Should you buy G Medical Innovations stock or one of its competitors? MarketBeat compares G Medical Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with G Medical Innovations include SmileDirectClub (SDCCQ), T2 Biosystems (TTOO), ViewRay (VRAYQ), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.

How does G Medical Innovations compare to SmileDirectClub?

SmileDirectClub (NASDAQ:SDCCQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
G Medical Innovations N/A N/A N/A

SmileDirectClub has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 28.55, suggesting that its stock price is 2,755% more volatile than the broader market.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
G Medical Innovations Neutral

G Medical Innovations has lower revenue, but higher earnings than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to T2 Biosystems?

T2 Biosystems (NASDAQ:TTOO) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, T2 Biosystems had 1 more articles in the media than G Medical Innovations. MarketBeat recorded 1 mentions for T2 Biosystems and 0 mentions for G Medical Innovations. T2 Biosystems' average media sentiment score of 0.67 beat G Medical Innovations' score of 0.00 indicating that T2 Biosystems is being referred to more favorably in the media.

Company Overall Sentiment
T2 Biosystems Positive
G Medical Innovations Neutral

T2 Biosystems has a beta of 7.71, meaning that its share price is 671% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 28.55, meaning that its share price is 2,755% more volatile than the broader market.

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
G Medical Innovations N/A N/A N/A

23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

G Medical Innovations has lower revenue, but higher earnings than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Summary

G Medical Innovations beats T2 Biosystems on 5 of the 9 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

ViewRay has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, G Medical Innovations has a beta of 28.55, meaning that its share price is 2,755% more volatile than the broader market.

In the previous week, ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
ViewRay Neutral
G Medical Innovations Neutral

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

G Medical Innovations has lower revenue, but higher earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33M-$0.31N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
G Medical Innovations N/A N/A N/A

Summary

G Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

G Medical Innovations (NASDAQ:GMVDF) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

G Medical Innovations has a beta of 28.55, meaning that its stock price is 2,755% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, meaning that its stock price is 467% more volatile than the broader market.

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Acutus Medical Neutral

G Medical Innovations has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Summary

G Medical Innovations beats Acutus Medical on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Minerva Surgical?

G Medical Innovations (NASDAQ:GMVDF) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

6.0% of G Medical Innovations shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Minerva Surgical Neutral

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Minerva Surgical N/A N/A N/A

G Medical Innovations has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

G Medical Innovations has a beta of 28.55, suggesting that its share price is 2,755% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, suggesting that its share price is 192% more volatile than the broader market.

Summary

G Medical Innovations beats Minerva Surgical on 4 of the 5 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDF vs. The Competition

Export
MetricG Medical InnovationsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$26K$41.50M$6.86B$12.25B
Dividend YieldN/A1.08%2.67%9.79%
P/E RatioN/A17.8327.1423.64
Price / SalesN/A28.68517.0189.03
Price / CashN/A18.8650.5459.64
Price / BookN/A8.4910.286.07
Net Income-$24.63M-$16.99M$3.60B$331.99M

G Medical Innovations Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-99.3%$19K$7.68MN/A180
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel